ReproCELL Incorporated (TYO:4978)
Japan · Delayed Price · Currency is JPY 140.00
+3.00 (2.19%)
Oct 6, 2026, 3:30 PM JST
ReproCELL Market Cap
ReproCELL has a market cap or net worth of 14.22 billion as of October 5, 2026. Its market cap has decreased by -19.67% in one year.
Market Cap
14.22B
Enterprise Value
8.61B
Revenue
2.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
140.00
ChartMarket Cap Chart
Since June 27, 2013, ReproCELL's market cap has decreased from 145.35B to 14.22B, a decrease of -90.21%. That is a compound annual growth rate of -16.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 14.22B | 7.30% |
| Dec 30, 2025 | 13.26B | 35.27% |
| Dec 30, 2024 | 9.80B | -34.19% |
| Dec 29, 2023 | 14.89B | -42.13% |
| Dec 30, 2022 | 25.73B | 35.26% |
| Dec 30, 2021 | 19.02B | -35.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stella Pharma | 16.89B |
| RaQualia Pharma | 15.80B |
| CanBas | 14.66B |
| AnGes | 14.36B |
| Immuno-Biological Laboratories | 10.77B |
| Kubota Pharmaceutical Holdings | 10.54B |
| StemRIM | 10.34B |
| K Pharma,Inc. | 8.87B |